{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:07:55Z","timestamp":1784675275254,"version":"3.55.0"},"reference-count":100,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"ENAABLERS"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/14787210.2021.1898946","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T09:41:31Z","timestamp":1615887691000},"page":"1353-1366","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":47,"title":["A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications"],"prefix":"10.1080","volume":"19","author":[{"given":"PP","family":"Skosana","sequence":"first","affiliation":[{"name":"School of Pharmacy, Sefako Makgatho Health Sciences University","place":["Ga-Rankuwa, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-6285","authenticated-orcid":false,"given":"N","family":"Schellack","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sefako Makgatho Health Sciences University","place":["Ga-Rankuwa, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-6972","authenticated-orcid":false,"given":"B","family":"Godman","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sefako Makgatho Health Sciences University","place":["Ga-Rankuwa, South Africa"]},{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde","place":["Glasgow, UK"]},{"name":"Karolinska Institutet Karolinska University Hospital Huddinge","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-1988","authenticated-orcid":false,"given":"A","family":"Kurdi","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde","place":["Glasgow, UK"]},{"name":"Hawler Medical University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4046-629X","authenticated-orcid":false,"given":"M","family":"Bennie","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kruger","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sefako Makgatho Health Sciences University","place":["Ga-Rankuwa, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-5713","authenticated-orcid":false,"given":"JC","family":"Meyer","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sefako Makgatho Health Sciences University","place":["Ga-Rankuwa, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,2]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-018-0336-y"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189621"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2845"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30605-4"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0125-x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-018-1021-z"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.09.002"},{"key":"e_1_3_4_11_1","unstructured":"National Department of Health South Africa. SURVEILLANCE FOR ANTIMICROBIAL RESISTANCE AND CONSUMPTION OF ANTIBIOTICS IN SOUTH AFRICA. 2018. [cited 2021 Mar 11]. Available from: http:\/\/www.health.gov.za\/index.php\/antimicrobial-resistance?download=3374:surveillance-for-antimicrobial-resistance"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00751"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30113-9"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30625-X"},{"key":"e_1_3_4_15_1","unstructured":"AVERT. HIV AND AIDS IN SOUTH AFRICA. 2018. [cited 2011 Mar 11]. Available from:https:\/\/www.avert.org\/professionals\/hiv-around-world\/sub-saharan-africa\/south-africa"},{"key":"e_1_3_4_16_1","first-page":"54","article-title":"THE SOUTH AFRICAN ANTIMICROBIAL RESISTANCE STRATEGY FRAMEWORK","author":"Mendelson M","year":"2015","unstructured":"Mendelson M, Matoso M. THE SOUTH AFRICAN ANTIMICROBIAL RESISTANCE STRATEGY FRAMEWORK. Amr Control. 2015;54\u201361.","journal-title":"Amr Control"},{"key":"e_1_3_4_17_1","unstructured":"World Health Organisation. Antimicrobial resistance. 2018. [cited 2021 Mar 1]. Available from: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30060-4"},{"key":"e_1_3_4_19_1","unstructured":"Interagency Coordination Group on Antimicrobial Resistance. NO TIME TO WAIT: SECURING THE FUTURE FROM DRUG-RESISTANT INFECTIONS - REPORT TO THE SECRETARY-GENERAL OF THE UNITED NATIONS APRIL 2019. [cited 2021 Mar 1]. Available from: https:\/\/www.who.int\/antimicrobial-resistance\/interagency-coordination-group\/IACG_final_report_EN.pdf?ua=1"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30516-4"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.05.007"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.16.181743"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70318-9"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.12527.1"},{"key":"e_1_3_4_25_1","unstructured":"Department of Health Republic of South Africa. ANTIMICROBIAL RESISTANCE NATIONAL STRATEGY FRAMEWORK 2014-2024. [cited 2021 Mar 1]. Available from: https:\/\/www.jpiamr.eu\/wp-content\/uploads\/2018\/10\/Antimicrobial-Resistance-National-Strategy-Framework-2014-2024_South-Africa.pdf"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv418"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614554919"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02725.x"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01156"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1417835"},{"issue":"46","key":"e_1_3_4_31_1","article-title":"Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017","volume":"23","author":"Plachouras D","year":"2018","unstructured":"Plachouras D, Karki T, Hansen S, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveillance. 2018;23(46).","journal-title":"Euro Surveillance"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30186-4"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70780-7"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1767593"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30681-4"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2713-1"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2016.1164040"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2020.1734719"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v7i2.796"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2018.1450605"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30398-X"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1629288"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2019.1632070"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1581063"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2018.09.003"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics3030450"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt301"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.250"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13042"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2015.990381"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr459"},{"key":"e_1_3_4_52_1","unstructured":"ECDC.Quality indicators for antibiotic consumption in the community in Europe. [cited 2021 Mar 1]. Available from: http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial-resistance-and-consumption\/antimicrobial-consumption\/esac-net-database\/Pages\/quality-indicators-primary-care.aspx"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30547-4"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30724-7"},{"key":"e_1_3_4_55_1","unstructured":"World Health Organization - Model List of Essential Medicines. 21st List 2019. [cited 2021 Mar 1]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2017.1382354"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01056-7"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30532-8"},{"key":"e_1_3_4_59_1","first-page":"1","article-title":"Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship","author":"Afriyie DK","year":"2020","unstructured":"Afriyie DK, Sefah IA, Sneddon J, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;1\u20139.","journal-title":"JAC Antimicrob Resist"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2017.1320220"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0055"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002072"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S253216"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky117"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzy172"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001324"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz321"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30332-7"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2019.1592880"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2021.1889213"},{"key":"e_1_3_4_71_1","doi-asserted-by":"crossref","unstructured":"Finlayson HVA Whitelaw A Goossens H et al.The global point prevalence survey of antimicrobial consumption and resistance (global-pps): results of antimicrobial prescribing in a South African tertiary hospital. 2016. [cited 2021 Mar 1]. Available from: http:\/\/www.global-pps.com\/wp-content\/uploads\/ECCMID-2016_South-Africa.pdf","DOI":"10.26226\/morressier.56d5ba2fd462b80296c95235"},{"key":"e_1_3_4_72_1","first-page":"169","article-title":"Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in Kenya: findings and implications","volume":"5","author":"Opanga SA","year":"2017","unstructured":"Opanga SA, Mwang\u2019ombe NJ, Okalebo FA, et al. Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in Kenya: findings and implications. Infect Dis Preve Med. 2017;5:169.","journal-title":"Infect Dis Preve Med"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-018-0299-z"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2018.04.019"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2018.1464872"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.4103\/jrpp.JRPP_18_68"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.4103\/atp.atp_38_17"},{"key":"e_1_3_4_78_1","unstructured":"Nsofor CA Amadi ES Ukwandu N et al. Prevalence of antimicrobial use in major hospitals in Owerri Nigeria. 2016;3.5:522\u2013527.EC MICROBIOLOGY"},{"key":"e_1_3_4_79_1","unstructured":"National Department of Health (NDoH). Regulations relating to categories of hospitals. Government Notices. Pretoria South Africa. 2012. [cited 2021 Mar 1]. Available from: http:\/\/www.health.gov.za\/index.php\/2014-03-17-09-09-38\/legislation\/joomla-split-menu\/category\/84-2012r?download=138:regulations-relating-to-categories-of-hospitals-r185-20122"},{"key":"e_1_3_4_80_1","unstructured":"ECDC. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. [cited 2021 Mar 1]. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/PPS-HAI-antimicrobial-use-EU-acute-care-hospitals-V5-3.pdf"},{"key":"e_1_3_4_81_1","unstructured":"WHO. WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index. 2020. [cited 2021 Mar 1]. Available from: https:\/\/www.whocc.no\/"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078942"},{"key":"e_1_3_4_83_1","unstructured":"WHO. WHO methodology for point prevalence survey on antibiotic use in hospitals. Version 1.1. 2019. [cited 2021 Mar 1]. Available from: https:\/\/www.who.int\/medicines\/access\/antimicrobial_resistance\/WHO-EMP-IAU-2018_01\/en\/"},{"key":"e_1_3_4_84_1","unstructured":"National department of health South Africa. essential drugs programme. hospital level (adults) standard treatment guidelines and essential medicines list. 5th ed. 2019. [cited 2021 Mar 1]. Available from: http:\/\/www.health.gov.za\/index.php\/standard-treatment-guidelines-and-essential-medicines-list\/category\/286-hospital-level-adults"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.898"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1543"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp268"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky118"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30493-6"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.7196\/samj.7262"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2020.1789389"},{"key":"e_1_3_4_92_1","unstructured":"WHO. Guidelines for the diagnosis prevention and management of cryptococcal disease in HIV-infected adults adolescents and children - supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Mar 2018. Available from: https:\/\/www.who.int\/hiv\/pub\/guidelines\/cryptococcal-disease\/en\/)"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2015.1025057"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05520-5"},{"key":"e_1_3_4_95_1","unstructured":"Saha SK Shaha KC Haque MF et al. Current trends of using antimicrobial drugs in the ICU at a tertiary level teaching hospital in mymensingh. 2016;25(4):657\u2013662.Mymensingh medical journal"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2020.1754687"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1086\/421095"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006903"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31817586c8"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2016.214"},{"key":"e_1_3_4_101_1","unstructured":"NICE. Surgical site infections: prevention and treatment treatment. NICE CG 74. 2008. Available from: https:\/\/www.nice.org.uk\/guidance\/cg74\/resources\/surgical-site-infections-prevention-and-treatment-pdf-975628422853"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa070"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2021.1898946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T09:56:39Z","timestamp":1766483799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2021.1898946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,2]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/14787210.2021.1898946"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2021.1898946","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}